ASEAN Markets: Since August 2024, XPOVIO ® has been successively approved in Malaysia, Thailand, and Indonesia, marking significant progress in Antengene's commercialization strategy across the APAC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback